Researcher
Judith FRAUSSEN
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Adaptive immunology, Autoimmunity, Biomarker discovery, Biomarker evaluation, Analysis of next-generation sequence data
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Oct 2011 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2011 → Today - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2011 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Member
From1 Oct 2011 → 31 Dec 2019 - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Mar 2011 → 30 Sep 2011 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Mar 2011 → 30 Sep 2011 - Immunology - Biochemistry (Research group)
Member
From1 Mar 2011 → 30 Sep 2011 - Biomedical Research Institute (Research institute)
Member
From1 Mar 2011 → 30 Sep 2011 - Biomedical Research Institute (Research institute)
Member
From1 Oct 2009 → 28 Feb 2011 - Physiology - Biochemistry - Immunology (Department)
Member
From16 Sep 2006 → 28 Feb 2011 - Immunology - Biochemistry (Research group)
Member
From16 Sep 2006 → 28 Feb 2011 - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Sep 2006 → 28 Feb 2011 - Medical Basic Sciences (Division)
Member
From16 Sep 2006 → 30 Sep 2009
Projects
1 - 10 of 14
- The MIF/CD74 system as driver of pro-inflammatory B cell functions and secondary neurodegeneration following traumatic spinal cord injuryFrom1 Jul 2022 → TodayFunding: Foreign foundations, funds with scientific view
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- The MIF-CD74 system as a driver of pro-inflammatory B cell responses following traumatic spinal cord injury (SCI).From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Understanding how B cell depletion with ocrelizumab affects the immune system in the treatment of MSFrom1 Jan 2021 → 30 Jun 2023Funding: Foundations, funds and other with scientific goal
- Validation of age-associated B cells as therapeutic targets in MSFrom1 Jan 2020 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Taxonomy, Treatment, Targets and Remission: Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic ConditionsFrom1 Sep 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Autologous hematopoietic stem cell transplantation (AHSCT) in MS: a role for B cells?From1 Jan 2019 → 30 Jun 2022Funding: Foundations, funds and other with scientific goal
- Age-associated B cells as therapeutic targets in MSFrom1 Jan 2019 → 30 Jun 2022Funding: Foundations, funds and other with scientific goal
- Defining how a novel B cell population contributes to MS pathologyFrom1 Apr 2016 → 31 Mar 2017Funding: Foreign public sponsor
- How aged B cells contribute to MS pathology.From1 Jan 2016 → 31 Dec 2018Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 40
- Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab(2024)
Authors: Lien BECKERS, Paulien BAETEN, Veronica POPESCU, Dries SWINNEN, Alessio CARDILLI, Ibrahim HAMAD, Bart VAN WIJMEERSCH, S.J. Tavernier, Markus KLEINEWIETFELD, Bieke BROUX, et al.
Pages: 109894 - Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Judith FRAUSSEN, Zoe PIETERS, Stef Thonissen, Niels HELLINGS, Piet STINISSEN, Ina CALLEBAUT, Joris PENDERS, Karolien VANHOVE, et al.
- IgD−CD27− double negative (DN) B cells: Origins and functions in health and disease(2023)
Authors: Lien BECKERS, Veerle SOMERS, Judith FRAUSSEN
Pages: 67 - 76 - Editorial: New Insights Into B Cell Subsets in Health and Disease(2022)
Authors: Veerle SOMERS, Deborah K. Dunn-Walters, Mirjam van der Burg, Judith FRAUSSEN
- Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity(2022)
Authors: Doryssa HERMANS, Evelien HOUBEN, Paulien BAETEN, Helena Slaets, Kris JANSSENS, Cindy HOEKS, Baharak HOSSEINKHANI, Gayel DURAN, Seppe BORMANS, Elizabeth Gowing, et al.
Pages: 259 - 281 - Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical Parameters(2022)
Authors: Judith FRAUSSEN, Lien BECKERS, CCM van Laake-Geelen, B Depreitere, J Deckers, EMJ Cornips, D Peuskens, Veerle SOMERS
- Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy(2022)
Authors: Valentino D'ONOFRIO, Lotte Keulen, Annelore Vandendriessche, Jasperina Dubois, Reinoud Cartuyvels, Marie-Elena Vanden Abeele, Judith FRAUSSEN, Patrick VANDORMAEL, Veerle SOMERS, Ruth ACHTEN, et al.
- IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity(2022)
Authors: Judith FRAUSSEN
- Characterisation of the innate and adaptive immune system after ocrelizumab treatment in multiple sclerosis(2021)
Authors: Lien BECKERS, Paulien BAETEN, Dries SWINNEN, Ibrahim HAMAD, S. Tavernier, Bart VAN WIJMEERSCH, Veronica POPESCU, Markus KLEINEWIETFELD, Bieke BROUX, Judith FRAUSSEN, et al.
Pages: 777 - 778 - IgD-CD27-double negative (DN) B cells of multiple sclerosis patients are mature memory cells that can migrate towards pro-inflammatory chemokines(2021)
Authors: Lien BECKERS, Gwendoline MONTES DIAZ, Luisa Maria Villar, Bart VAN WIJMEERSCH, Veronica POPESCU, Veerle SOMERS, Judith FRAUSSEN
Pages: 187
Linked dataset
1 - 1 of 1
- Immune phenotyping SCI patients versus healthy controls (Rights Holder)